353258-35-2 Usage
General Description
8-Chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid is a chemical compound that belongs to the class of pyridine carboxylic acids and is characterized by the presence of a chloro and trifluoromethyl group. It is a synthetic compound with potential antineoplastic and antibacterial properties. This chemical has been investigated for its potential in the treatment of cancer and infectious diseases. It has also demonstrated activity against a range of bacterial strains, making it a potential candidate for the development of new antibiotics. The compound's structure and properties make it suitable for further research and potential application in pharmaceutical and medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 353258-35-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,3,2,5 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 353258-35:
(8*3)+(7*5)+(6*3)+(5*2)+(4*5)+(3*8)+(2*3)+(1*5)=142
142 % 10 = 2
So 353258-35-2 is a valid CAS Registry Number.
353258-35-2Relevant articles and documents
Nitrogenous heterocyclic compound with nematocidal activity, preparation method and application thereof
-
, (2018/07/30)
The invention relates to a nitrogenous heterocyclic compound with nematocidal activity, a preparation method and application thereof. Specifically, the invention discloses a compound with a formula (I) or an optical isomer, cis-trans isomer or acceptable salt in agricultural pharmacology and a preparation method thereof. The invention further discloses an agricultural composition containing the compound and application thereof. The compound has excellent nematocidal activity.
HETERCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
-
, (2018/12/13)
Described herein are heterocyclic compounds, compositions, and methods for their use for treatment of disease.
HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
-
, (2017/06/01)
Described herein are heterocyclic compounds, compositions, and methods for their use for the treatment of disease.